Patent details

LUC00178 Product Name: Léfamuline, sels et solvates de celle-ci

Basic Information

Publication number:
LUC00178
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP087142949
Legal Status:
Inactive
Application number:
LUC00178
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/20/1457
Marketing Authorization Type:
Marketing Authorization Date:
28/07/2020
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
06/10/2020
First Marketing Authorization date:
28/07/2020
Grant date:
14/12/2021
Activation date:
Publication date:
06/10/2020
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
19/03/2033
SPC Extension Expiration:
19/03/2033
Rejection date:
Withdrawal date:

Owner

From:
06/10/2020
 
 

Name:
Nabriva Therapeutics GmbH
Address:
Leberstrasse 20, 1110 Wien, Austria (AT)

Agent

Name:
ARONOVA S.A.
From:
06/10/2020
Address:
PO Box 327, 4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC1
Bulletin edition number:
2020/12
Publication date:
02/11/2020
Description:
Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:
SPC2
Bulletin edition number:
2022/01
Publication date:
03/01/2022
Description:
Section D : Granted supplementary protection certificates – I2 publication

Annual Fees

Annual Fee Due Date:
31/03/2028
Annual Fee Number:
21
Annual Fee Amount:
410 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
06/10/2020 General Document 60
06/10/2020 Summary of the product caracteristics 56
06/10/2020 Marketing authorization 3
06/10/2020 MA publication 52
06/10/2020 Outgoing Correspondence 1
06/10/2020 Application Form 4
13/08/2021 Incoming Correspondence (Post) 1
06/10/2020 Publication 1
14/12/2021 Publication 1
14/12/2021 Certificate 1
14/12/2021 Outgoing Correspondence 1